Skip to main content
. 2024 Jan 2;19(1):e0295205. doi: 10.1371/journal.pone.0295205

Fig 5. Effectiveness and safety of mTORi vs MMF within patients treated with TAC.

Fig 5

Note. CsA: Cyclosporine; TAC: Tacrolimus; mTORi: Mammalian target of rapamycin inhibitors; MMF: Mycophenolate; PY: Person-years; HR: Hazard ratio; 95%CI: 95% confidence interval; MACE: Major adverse cardiovascular events.